OneMedNet Corporation has secured more than $3 million in new bookings year-to-date for 2026, surpassing the company's total bookings for all of full-year 2025. The company expects to recognize substantially all of these bookings as revenue by the end of the third quarter of 2026. This milestone reflects strong commercial traction for OneMedNet's iRWD™ Platform, powered by Palantir Foundry, as life sciences organizations increasingly utilize its multi-modal, imaging-centric Real-World Data for regulatory submissions and AI model development.

The rapid pace of contracting highlights surging market demand for fit-for-purpose multi-modal datasets and the operational scalability OneMedNet has achieved. This builds on the company's recent milestone of surpassing 90 million patient journeys and 270 million studies across its network of more than 2,300 healthcare partner sites.

Key Highlights

Growth Drivers

The company's growth is driven by new customer wins and expanded engagements with life sciences, medical device, and AI-focused clients. These clients are using the iRWD™ platform for foundation model development, cohort discovery, feasibility studies, and regulatory-grade data delivery. The rapid bookings-to-revenue cycle validates the strength of OneMedNet's data curation, tokenization, and delivery infrastructure.

OneMedNet expects continued momentum in the second half of 2026 as additional pipeline opportunities advance and existing customers deepen their use of the platform. The company is preparing to close out the second quarter with positive tailwinds and enter the second half of the year with strong momentum.